• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).

作者信息

Li Marilyn M, Chao Elizabeth, Esplin Edward D, Miller David T, Nathanson Katherine L, Plon Sharon E, Scheuner Maren T, Stewart Douglas R

机构信息

Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Division of Genetic and Genomic Medicine, University of California, Irvine, School of Medicine, Irvine, CA, USA.

出版信息

Genet Med. 2020 Jul;22(7):1142-1148. doi: 10.1038/s41436-020-0783-8. Epub 2020 Apr 23.

DOI:10.1038/s41436-020-0783-8
PMID:32321997
Abstract
摘要

相似文献

1
Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).肿瘤检测患者种系变异报告的注意事项：美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2020 Jul;22(7):1142-1148. doi: 10.1038/s41436-020-0783-8. Epub 2020 Apr 23.
2
Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).生殖系基因和基因组检测中获得性变异的偶然发现：美国医学遗传学与基因组学学会（ACMG）的一份要点声明
Genet Med. 2021 Jul;23(7):1179-1184. doi: 10.1038/s41436-021-01138-5. Epub 2021 Apr 16.
3
Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG).使用下一代测序检测种系结构变异时需考虑的要点：美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2023 Feb;25(2):100316. doi: 10.1016/j.gim.2022.09.017. Epub 2022 Dec 12.
4
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.1清单：一项政策声明
Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.
5
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.0清单：一项政策声明
Genet Med. 2021 Aug;23(8):1381-1390. doi: 10.1038/s41436-021-01172-3. Epub 2021 May 20.
6
Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).基于家庭的临床基因组检测中评估关系（或怀疑关系错误归因）时需考虑的要点：美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2020 Aug;22(8):1285-1287. doi: 10.1038/s41436-020-0821-6. Epub 2020 May 14.
7
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).ACMG SF v3.2 临床外显子组和基因组测序中报告次要发现的列表：美国医学遗传学与基因组学学会 (ACMG) 的政策声明。
Genet Med. 2023 Aug;25(8):100866. doi: 10.1016/j.gim.2023.100866. Epub 2023 Jun 22.
8
Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).临床实验室染色体结构变异的新一代测序检测：2021 年修订版：美国医学遗传学与基因组学学会（ACMG）的技术标准。
Genet Med. 2021 Aug;23(8):1399-1415. doi: 10.1038/s41436-021-01139-4. Epub 2021 Apr 29.
9
Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG).避免不公平歧视和基因信息滥用需考虑的要点：美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2022 Mar;24(3):512-520. doi: 10.1016/j.gim.2021.11.002. Epub 2021 Dec 16.
10
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).临床外显子组和基因组测序中次要发现报告的建议，2021年更新：美国医学遗传学与基因组学学会（ACMG）政策声明
Genet Med. 2021 Aug;23(8):1391-1398. doi: 10.1038/s41436-021-01171-4. Epub 2021 May 20.

引用本文的文献

1
Genetic variations and recurrence in stage III Korean colorectal cancer: Insights from tumor-only mutation analysis.Ⅲ期韩国结直肠癌的基因变异与复发：仅肿瘤突变分析的见解
PLoS One. 2025 May 23;20(5):e0323302. doi: 10.1371/journal.pone.0323302. eCollection 2025.
2
Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report.通过遗传性癌症基因检测诊断的骨髓增生异常综合征：一例报告
NPJ Genom Med. 2025 May 15;10(1):39. doi: 10.1038/s41525-025-00476-6.
3
Hereditary Colorectal Cancer: Clinical Implications of Genomic Medicine and Precision Oncology.
遗传性结直肠癌：基因组医学与精准肿瘤学的临床意义
J Anus Rectum Colon. 2025 Apr 25;9(2):167-178. doi: 10.23922/jarc.2025-001. eCollection 2025.
4
Clinical classification and molecular interpretation of germline pathogenic TP53 variations detected by multigene panel testing in patients with possible cancer predisposition.通过多基因检测面板在可能具有癌症易感性的患者中检测到的种系致病性TP53变异的临床分类和分子解读
Mol Genet Genomics. 2025 Apr 24;300(1):45. doi: 10.1007/s00438-025-02250-w.
5
Incorporating Structured and Unstructured Data Sources to Identify and Characterize Hereditary Cancer Testing Among Veterans With Metastatic Castration-Resistant Prostate Cancer.整合结构化和非结构化数据源，以识别和描述转移性去势抵抗性前列腺癌退伍军人中的遗传性癌症检测情况。
JCO Clin Cancer Inform. 2025 Feb;9:e2400189. doi: 10.1200/CCI-24-00189. Epub 2025 Feb 10.
6
Clinical integration of germline findings from a tumor testing precision medicine program.肿瘤检测精准医学项目中种系结果的临床整合
BMC Cancer. 2025 Jan 30;25(1):176. doi: 10.1186/s12885-025-13487-4.
7
Molecular characterization of gliomas and glioneuronal tumors amid Noonan syndrome: cancer predisposition examined.努南综合征患者中神经胶质瘤和神经胶质神经元肿瘤的分子特征：对癌症易感性的研究
Front Oncol. 2024 Sep 6;14:1453309. doi: 10.3389/fonc.2024.1453309. eCollection 2024.
8
Comparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study.比较德克萨斯州儿童癌症研究中多样化人群中胚系外显子组与面板测序的诊断产量。
JCO Precis Oncol. 2024 Sep;8:e2400187. doi: 10.1200/PO.24.00187.
9
Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports.肿瘤下一代测序报告中分子肿瘤委员会审查对可能胚系致病性变异体识别的临床实用性。
JCO Precis Oncol. 2024 Sep;8:e2400301. doi: 10.1200/PO.24.00301.
10
Germline susceptibility from broad genomic profiling of pediatric brain cancers.儿童脑癌广泛基因组分析中的种系易感性。
Neurooncol Adv. 2024 Jun 15;6(1):vdae099. doi: 10.1093/noajnl/vdae099. eCollection 2024 Jan-Dec.